SCHEMBL6954085

SCHEMBL6954085

Cc1c(-c2ccccc2)oc(=O)c(Sc2ccccc2)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2C19 P33261 3/20 0.42
TSHR P16473 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
KDM4E B2RXH2 7/20 0.40
RXFP1 Q9HBX9 2/20 0.40
MAPT P10636 5/20 0.39
LMNA P02545 4/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
TP53 P04637 3/20 0.38
ALOX15 P16050 3/20 0.38
ABCB1 P08183 3/20 0.38
MAPK1 P28482 2/20 0.38
CA12 O43570 2/20 0.38
CYP1B1 Q16678 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536182 0.83 ALDH1A1 (0.36) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL6956354 0.83 KDM4E (0.42) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL23925906 0.72 CYP3A4 (0.46) CYP3A4ALDH1A1CYP2C9CYP2C19TSHR
SCHEMBL13442671 0.71 KDM4E (0.38) CYP3A4ALDH1A1CYP2C9CYP2C19TDP1
SCHEMBL11792467 0.71 MEN1 (0.45) ALDH1A1TDP1KDM4ERXFP1MAPT
SCHEMBL10985533 0.71 KDM4E (0.54) CYP3A4ALDH1A1CYP2C9CYP2C19TSHR
SCHEMBL8539122 0.71 CYP19A1 (0.36) ALDH1A1TDP1KDM4ERXFP1MAPT
SCHEMBL8539120 0.71 MEN1 (0.34) ALDH1A1CYP2C9CYP2C19KDM4ERXFP1
SCHEMBL13442674 0.70 KDM4E (0.42) CYP3A4ALDH1A1KDM4ERXFP1MAPT
SCHEMBL7397801 0.70 SMN1; SMN2 (0.54) CYP3A4ALDH1A1CYP2C9CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US claimed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed